Rhythm’s lead biomarker successfully differentiates between cancer and healthy samples
Sep 19, 2019
Sep 19, 2019 |
New antibodies for the key lead biomarker used in Rhythm Biosciences' (ASX: RHY) ColoSTAT® test can successfully differentiate between cancer and healthy samples, and the test has now been optimised.
Rhythm Biosciences making progress in 1000 patient trial
Aug 7, 2019
Aug 7, 2019 |
Rhythm Biosciences Ltd (ASX:RHY) is continuing to develop its global, low-cost, lifesaving blood test for the detection of colorectal cancer, ColoSTAT®.
Australia’s top biotechs descend on Queenstown for the 2019 Bioshares Summit
Jul 25, 2019
Jul 25, 2019 |
Queenstown, the New Zealand extreme sport mecca, hosts the annual Bioshares Biotech Summit, gathering together some of the best long-standing and emerging biotech companies in the country to talk all things trials, tribulations and potential cures for cancer.